WallStSmart

Cryoport Inc (CYRX)vsPACCAR Inc (PCAR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PACCAR Inc generates 15086% more annual revenue ($27.78B vs $182.94M). CYRX leads profitability with a 43.6% profit margin vs 8.9%. PCAR appears more attractively valued with a PEG of 1.27. PCAR earns a higher WallStSmart Score of 54/100 (C-).

CYRX

Hold

46

out of 100

Grade: D+

Growth: 4.7Profit: 5.5Value: 4.0Quality: 6.0
Piotroski: 4/9Altman Z: 0.39

PCAR

Buy

54

out of 100

Grade: C-

Growth: 4.0Profit: 6.0Value: 4.7Quality: 6.5
Piotroski: 1/9Altman Z: 2.09
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CYRX.

PCARSignificantly Overvalued (-62.2%)

Margin of Safety

-62.2%

Fair Value

$85.20

Current Price

$133.87

$48.67 premium

UndervaluedFair: $85.20Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CYRX3 strengths · Avg: 8.7/10
Profit MarginProfitability
43.6%10/10

Keeps 44 of every $100 in revenue as profit

Price/BookValuation
1.7x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
16.5%8/10

16.5% revenue growth

PCAR1 strengths · Avg: 9.0/10
Market CapQuality
$69.00B9/10

Large-cap with strong market position

Areas to Watch

CYRX4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$807.95M3/10

Smaller company, higher risk/reward

PEG RatioValuation
62.132/10

Expensive relative to growth rate

Free Cash FlowQuality
$-6.55M2/10

Negative free cash flow — burning cash

PCAR3 concerns · Avg: 3.0/10
P/E RatioValuation
26.9x4/10

Moderate valuation

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

Revenue GrowthGrowth
-8.9%2/10

Revenue declined 8.9%

Comparative Analysis Report

WallStSmart Research

Bull Case : CYRX

The strongest argument for CYRX centers on Profit Margin, Price/Book, Revenue Growth. Profitability is solid with margins at 43.6% and operating margin at -20.1%. Revenue growth of 16.5% demonstrates continued momentum.

Bull Case : PCAR

The strongest argument for PCAR centers on Market Cap. PEG of 1.27 suggests the stock is reasonably priced for its growth.

Bear Case : CYRX

The primary concerns for CYRX are EPS Growth, Market Cap, PEG Ratio.

Bear Case : PCAR

The primary concerns for PCAR are P/E Ratio, Piotroski F-Score, Revenue Growth.

Key Dynamics to Monitor

CYRX profiles as a growth stock while PCAR is a value play — different risk/reward profiles.

CYRX carries more volatility with a beta of 1.89 — expect wider price swings.

CYRX is growing revenue faster at 16.5% — sustainability is the question.

PCAR generates stronger free cash flow (825M), providing more financial flexibility.

Bottom Line

PCAR scores higher overall (54/100 vs 46/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cryoport Inc

INDUSTRIALS · INTEGRATED FREIGHT & LOGISTICS · USA

Cryoport, Inc., a life sciences services company, provides temperature controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific. The company is headquartered in Brentwood, Tennessee.

Visit Website →

PACCAR Inc

INDUSTRIALS · FARM & HEAVY CONSTRUCTION MACHINERY · USA

PACCAR Inc is an American Fortune 500 company and counts among the largest manufacturers of medium- and heavy-duty trucks in the world. PACCAR is engaged in the design, manufacture and customer support of light-, medium- and heavy-duty trucks under the Kenworth, Peterbilt, Leyland Trucks, and DAF nameplates. PACCAR also designs and manufactures powertrains, provides financial services and information technology, and distributes truck parts related to its principal business.

Want to dig deeper into these stocks?